Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Precision HealthPGx Panel (25 Genes) RPRD Diagnostics, LLC United States | 97 | 23 |
|
RPRD Diagnostics, LLC United States | 107 | 69 |
|
Hereditary Hemolytic Anemia Comprehensive Sequencing, Varies Mayo Clinic Laboratories Mayo Clinic United States | 39 | 40 |
|
Eugenomic S.L. Spain | 1 | 16 |
|
G6PD Gene Favism, susceptibility to NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
G6PD Gene Hemolytic anemia due to G6PD deficiency NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Red Blood Cell Enzyme Panel, Next-Generation Sequencing Mayo Clinic Laboratories Mayo Clinic United States | 19 | 17 |
|
Glucose-6-Phosphate Dehydrogenase (G6PD) Full Gene Sequencing Mayo Clinic Laboratories Mayo Clinic United States | 9 | 1 |
|
Tempus Labs, Inc. United States | 2 | 646 |
|
Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 1 | 1 |
|
BloodGenetics Spain | 33 | 36 |
|
Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States | 21 | 17 |
|
Pharmacogenomics Profile + HLA AccessDx Lab LLC United States | 71 | 38 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 107 | 96 |
|
BloodGenetics Spain | 12 | 17 |
|
Eugenomic S.L. Spain | 1 | 16 |
|
Eugenomic S.L. Spain | 1 | 21 |
|
Centogene AG - the Rare Disease Company Germany | 195 | 203 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.